Cardiac arrhythmia-detection startup BioSig Technologies (NSDQ:BSGM) has received nearly $1 million in financing from the Mayo Clinic after working with the healthcare organization for two years. BioSig recently completed first-in-human studies at the Rochester, Minn.-based clinic aimed at validating the safety and efficacy of its Pure EP system during mapping and ablation procedures in a cardiac EP lab. Patient […]
BioSig raises $9m
BioSig Technologies (OTCQB: BSGM) has raised $8.6 million in a new round of equity financing, according to a recently posed SEC filing. The Santa Monica, Calif.-based company is developing the Pure EP system, which is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. […]
BioSig inks Pure EP first-in-human study deal with Texas Cardiac Arrhythmia Institute
BioSig Technologies (OTCQB: BSGM) said today that it inked a deal with Austin’s Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to launch first-in-human studies using its Pure EP system. The Santa Monica, Calif.-based company’s Pure EP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals […]
BioSig to uplist to NASDAQ exchange
BioSig Technologies (OTCQB: BSGM) said this week it plans to uplist onto the Nasdaq Capital Market, beginning today. The Santa Monica, Calif.-based company said that the uplisting follows its receipt of FDA 510(k) clearance for its Pure EP electrophysiology system. BioSig said that the PureEP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, […]
BioSig raises $4m
BioSig Technologies (OTCQB: BSGM) has raised $4.1 million in a new round of equity and warrants financing, according to a recently posted SEC filing. The Santa Monica, Calif.-based company is looking for an additional $5.9 million before closing the round, aiming to raise a total of $10 million in the round. Funding in the round came from […]
Report: Amazon adds MGH cardiologist Majmudar | Personnel Moves – August 21, 2018
Amazon (NSDQ:AMZN) has picked up well-known cardiologist Dr. Maulik Majmudar for a new role within the company as it looks to continue its foray into healthcare, according to a recent CNBC report. The announcement was made by Majmudar himself on Twitter, according to the report, though he did not state what his specific role within the […]
BioSig wins FDA nod for Pure EP system
BioSig Technologies (OTCQB: BSGM) said today it won FDA 510(k) clearance for its Pure EP electrophysiology system. The Santa Monica, Calif.-based company said the PureEP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. The newly cleared system is intended to reduce […]
MRI Interventions taps ex-Philips exec Burnett as prez, CEO | Personnel Moves – Oct 19, 2017
MRI Interventions (OTC:MRIC) said early this month it tapped former Royal Philips (NYSE:PHG) neuro diagnostics & therapy biz GM Joseph Burnett as its new prez & CEO, effective November 7. Burnett will replace Frank Grillo who will stay in his role until November 6 and will continue to serve as an executive advisor afterwards, the Irvine, Calif.-based […]
BioSig Tech raises $2m
BioSig Technologies (OTCQB: BSGM) has raised $1.6 million in a new round of equity and options financing, according to an SEC filing posted recently. Funding came from 22 anonymous investors, according to the filing, with the company looking to raise an additional $5.4 million before closing the round. The $1.6 million raised represents and aggregate consideration of […]
Avita Medical taps ex-Novartis exec Perry for CEO as it shifts focus to US | Personnel Moves June 9, 2017
Avita Medical (ASX:AVH) said last week it tapped former Novartis (NYSE:NVS) global biz dev & licensing chief scientific officer Dr. Michael Perry as its new chief executive officer, replacing resigning CEO Adam Kelliher. Dr. Perry served as a non-exec director of Avita since Feb 2013, according to the company, and held positions with Novartis including chief scientific […]
BioSig inks strategic partnership deal with Mayo Clinic
BioSig Technologies (OTCQB: BSGM) said today it inked a 10-year strategic agreement with the Mayo Clinic to develop advanced clinical features and applications for its Pure EP system. The new agreement expands on an earlier Advanced Clinical Research Program between BioSig and the Mayo clinic signed last March. “We are pleased to strengthen and broaden our relationship with […]
MassDevice Network
@MassDevice
LinkedIn
YouTube